Wockhardt Limited Share Price and Company Fundamentals
Last traded: Today at 4:22 AM
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine, as well as offers insulin aspart regular and biphasic drug products. Further, the company offers delivery devices for insulin, including DispoPen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
Key Metrics
PE ratio
87.66
PB ratio
7.16
Dividend yield
-
Beta
0.97
Market cap
₹354.25B
Enterprise value
₹380.43B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 2564 |
| Website | https://www.wockhardt.com |
| Mailing address | Wockhardt Towers Bandra Kurla Complex Bandra (East) Mumbai 400051 India |
| Phone / Fax | 91 24 0669 4444 / |
Dividends
Dividend yield
-
Dividend amount
₹-
Payout ratio
0.00%
5Y Avg. yield
-%
Wockhardt Limited paid ₹- dividend and the ex-dividend date was 17 Nov 2016.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.WOCKPHARMA dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Sep 2026, following are the company executives and directors listed on Wockhardt Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Habil Fakhruddin Khorakiwala | Founder & Executive Chairman | 82 | |
| Dr. Murtaza Habil Khorakiwala | MD & Executive Director | 52 | |
| Dr. Sachin Bhagwat | Chief Scientific Officer | ||
| Dr. Huzaifa Habil Khorakiwala | Executive Director | 55 | |
| Mr. Deepak R. Madnani | Chief Financial Officer | ||
| Mr. Sumit Garg | Chief Digital & Information Officer (CDIO) | ||
| Ms. Rashmi Dinesh Mamtura | Company Secretary & Compliance Officer | ||
| Ms. Debolina Partap | Senior Vice President of Legal | ||
| Mr. Satej Mehta | Head of Human Resource | ||
| Mr. Anil V. Kamath AMRSH (Lon.), BCom (Hons), MBIM (Lon.), MIMA | Senior Vice President of Business Development | 74 |
Profitability and management effectiveness
Profit margin
11.20%
Operating margin
14.32%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Wockhardt Limited is 354.25B and its enterprise value is 380.43B. The enterprise value to revenue ratio of WOCKPHARMA is 10.41. The enterprise value to EBITDA ratio of WOCKPHARMA is 50.84.
The WOCKPHARMA's stocks Beta value is 0.97 making it 3% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Wockhardt Limited (NSE:WOCKPHARMA) Frequently Asked Questions
1. What is Wockhardt Limited's Stock Symbol?
Wockhardt Limited trades on NSE under the ticker symbol "WOCKPHARMA".
2. What is Wockhardt Limited's stock price today?
One share of WOCKPHARMA stock can currently be purchased for approximately ₹2180.1.
3. How can I contact Wockhardt Limited?
Wockhardt Limited's mailing address is Wockhardt Towers Bandra Kurla Complex Bandra (East) Mumbai 400051 India. The company can be reached via phone at 91 24 0669 4444.
4. What is Wockhardt Limited's official website?
The official website of Wockhardt Limited is https://www.wockhardt.com.